Skip to main content

Table 2 Characteristics of patients who underwent secondary metastasectomy

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

  Metastatic sites Response TTP (months) Relapse
Patient 1 Liver CR 12 No
Patient 2 Liver PR 13 Yes (Liver)
Patient 3 Lung PR 4 No
Patient 4 Liver PR 9 No
Patient 5 Liver CR 11 Yes (Lung)
Patient 6 Lung PR 18 No
Patient 7 Liver PR 7 No
Patient 8 Liver PR 14 No